Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform

Frontiers in Microbiology

Volumn 3, Issue APR, 2012, Pages

  Dai, Tianhong ^a,b   Fuchs, Beth B ^a   Coleman, Jeffrey J ^a   Prates, Renato A ^c,i   Astrakas, Christos ^d   St Denis, Tyler G ^a,e   Ribeiro, Martha S ^c   Mylonakis, Eleftherios ^a   Hamblin, Michael R ^a,b,f   Tegos, George P ^a,b,g,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^d DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Biofilms; Clinical applications; Multidrug efflux systems; Permeability barrier; Photodynamic inactivation; Photodynamic therapy; Photosensitizer; Reactive oxygen species

Indexed keywords

EID: 84872050440     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00120     Document Type: Review

References (150)

1. Abruzzo, G., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H, Kropp, H, and Bartizal, K. (1997). Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficaecies in mouse models of disseminanted aspergillosis, candidiasis and cryptococcosis. Antimicrob. Agents Chemother. 41, 2333-2338.
2. Alanio, A., Desnos-Ollivier, M., and Dromer, F. (2011). Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. MBio 2, e00158-11.
3. Ameen, M. A. R. (2009). Developments in the management of mycetomas. Clin. Exp. Dermatolol. 32, 1-7.
4. Apidianakis, Y., Mindrinos, M. N., Xiao, W., Tegos,G. P., Papisov,M. I., Hamblin, M. R., Davis, R. W., Tompkins, R. G., and Rahme, L. G. (2007). Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS ONE 2, e1356. doi:10.1371/journal.pone.0001356
5. Apidianakis, Y., Que, Y.-A., Xu, W., Tegos, G. P., Zimniak, P., Hamblin, M. R., Tompkins, R. G., Xiao, W., and Rahme, L. G. (2011). Down-regulation of glutathione S-transferase alpha 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J. 2, 730-737.
6. Bertoloni, G., Reddi, E., Gatta, M., Burlini, C., and Jori, G. (1989). Factors influencing the haematoporphyrin-sensitized photoinactivation of Candida albicans. J. Gen. Microbiol. 135, 957-966.
7. Bertoloni, G., Rossi, F., Valduga, G., Jori, G., Ali, H., and Van Lier, J. E. (1992). Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 71, 33-46.
8. Biel, M. (2010). Photodynamic therapy of bacterial and fungal biofilm infections. Methods Mol. Biol. 635, 175-194.
9. Bisland, S., Chien, C., Wilson, B. C., and Burch, S. (2006). Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem. Photobiol. Sci. 5, 31-38.
10. Bliss, J. M., Bigelow, C. E., Foster, T. H., and Haidaris, C. G. (2004). Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob. Agents Chemother. 48, 2000-2006.
11. Bombelli, C., Bordi, F., Ferro, S., Giansanti, L., Jori, G., Mancini, G., Mazzuca, C., Monti, D., Ricchelli, F., Sennato, S., and Venanzi, M. (2008). New cationic liposomes as vehicles of mtetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases. Mol. Pharm. 5, 672-679.
12. Braham, P., Herron, C., Street, C., and Darveau, R. (2009). Antimicrobial photodynamic therapy may promote periodontal healing through multiple mechanisms. J. Periodontol. 80, 1790-1798.
13. Brizendine, K. P., and Pappas, P. G. (2010). Cryptococcal meningitis: current approaches to management in patients with and without AIDS. Curr. Infect. Dis. Rep. 12, 299-305.
14. Brombacher, K., Fischer, B. B., Rüfenacht, K., and Eggen, R. I. (2006). The role of Yap1p and Skn7p-mediated oxidative stress response in the defence of Saccharomyces cerevisiae against singlet oxygen. Yeast 23, 741-750.
15. Calzavara-Pinton, P. G., Venturini, M., and Sala, R. (2005). A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B Biol. 78, 1-6.
16. Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., and Monk, B. C. (2009). Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev. 22, 291-321.
17. Caston-Osorio, J. A., Rivero, A., and Torre-Cisneros, J. (2008). Epidemiology of invasive fungal infection. Int. J. Antimicrob. Agents 32(Suppl.2), S103-S109.
18. Chabrier-Roselló,Y., Foster,T. H., Mitra, S., and Haidaris,C. G. (2008). Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Photochem. Photobiol. 84, 1141-1148.
19. Chabrier-Rosello,Y.,Foster, T. H., Perez-Nazario, N., Mitra, S., and Haidaris, C. G. (2005). Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob. Agents Chemother. 49, 4288-4295.
20. Chabrier-Roselló, Y., Giesselman, B. R., De Jesús-Andino, F. J., Foster, T. H., Mitra, S., and Haidaris, C. G. (2010). Inhibition of electron transport chain assembly and function promotes photodynamic killing of Candida. J. Photochem. Photobiol. B Biol. 99, 117-125.
21. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., Mccormick, T., and Ghannoum, M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183, 5385-5394.
22. Coleman, J., Okoli, I., Tegos, G. P., Holson, E. B., Wagner, F. F., Hamblin, M. R., and Mylonakis, E. (2010). Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem. Biol. 5, 321-332.
23. Costa, A., De Campos Rasteiro, V. M., Pereira, C. A., Da Silva Hashimoto, E. S, Beltrame, M. Jr., Junqueira, J. C., and Jorge, A. O. (2011). Susceptibility of Candida albicans and Candida dubliniensis to erythrosine- and LED-mediated photodynamic therapy. Arch. Oral Biol. 56, 1299-1305.
24. Costa, A., Rasteiro, V. M., Pereira, C. A., Rossoni, R. D., Junqueira, J. C., and Jorge, A. O. (2012). The effects of rose bengal- and erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses 55, 56-63.
25. Crump, J., and Collignon, P. J. (2000). Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19, 1-8.
26. Dai, T., Bil, D. E., Arce, V. J., Tegos, G. P., and Hamblin, M. R. (2011a). Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob. Agents Chemother. 55, 5710-5717.
27. Dai, T., Kharkwal, G. B., Tanaka, M., Huang, Y. Y., Bil De Arce, V. J., and Hamblin, M. R. (2011b). Animal models of external traumatic wound infections. Virulence 2, 296-315.
28. Donnelly, R., Mccarron, P. A., Tunney, M. M., and David Woolfson, A. (2007). Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J. Photochem. Photobiol. B Biol. 86, 59-69.
29. Donnelly, R. F., Mccarron, P. A., Lightowler, J. M., and Woolfson, A. D. (2005). Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J. Control Release. 103, 381-392.
30. Dovigo, L., Pavarina, A. C., Mima, E. G., Giampaolo, E. T., Vergani, C. E., and Bagnato, V. S. (2011a). Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 54, 123-130.
31. Dovigo, L., Pavarina, A. C., Carmello, J. C., Machado, A. L., Brunetti, I. L., and Bagnato, V. S. (2011b). Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin. Lasers Surg. Med. 43, 927-934.
32. D'Souza, C., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., Jung, W. H., Sham, A., Kidd, S. E., Tangen, K., Lee, N., Zeilmaker, T., Sawkins, J., Mcvicker, G., Shah, S., Gnerre, S., Griggs, A., Zeng, Q., Bartlett, K., Li, W., Wang, X., Heitman, J., Stajich, J. E., Fraser, J. A., Meyer, W., Carter, D., Schein, J., Krzywinski, M., Kwon-Chung, K. J., Varma, A., Wang, J., Brunham, R., Fyfe, M., Ouellette, B. F., Siddiqui, A., Marra, M., Jones, S., Holt, R., Birren, B. W., Galagan, J. E., and Cuomo, C. A. (2011). Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts.MBio2, e00342.
33. Dutta, S., Ongarora,B.G., Li, H.,Vicente Mda, G., Kolli, B. K., and Chang, K. P. (2011). Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine. PLoS ONE 6, e20786. doi:10.1371/journal.pone.0020786
34. Ehrenshaft, M., Jenns, A. E., Chung, K. R., and Daub, M. E. (1998). SOR1, a gene required for photosensitizer and singlet oxygen resistance in Cercospora fungi, is highly conserved in divergent organisms. Mol. Cell 1, 603-609.
35. Engelhardt, V., Krammer, B., and Plaetzer, K. (2010). Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus. Photochem. Photobiol. Sci. 9, 365-369.
36. Espinel-Ingroff, A. (1998). Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36, 2950-2956.
37. Feldmesser, M., Kress, Y., Mednick, A., and Casadevall, A. (2000). The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J. Infect. Dis. 182, 1791-1795.
38. Ferro, S., Ricchelli, F., Mancini, G., Tognon, G., and Jori, G. (2006). Inactivation of methicillin resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents. J. Photochem. Photobiol. B Biol. 83, 98-104.
39. Foley, J. W., Song, X., Demidova, T. N., Jalil, F., and Hamblin, M. R. (2006). Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers. J. Med. Chem. 49, 5291-5299.
40. Fontana, C., Abernethy, A. D., Som, S., Ruggiero, K., Doucette, S., Marcantonio, R. C., Boussios, C. I., Kent, R., Goodson, J. M., Tanner, A. C., and Soukos, N. S. (2009). The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J. Periodont. Res. 44, 751-759.
41. Foote, C. S. (1991). Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54, 659.
42. Friedberg, J., Skema, C., Baum, E. D., Burdick, J., Vinogradov, S. A., Wilson, D. F., Horan, A. D., and Nachamkin, I. (2001). In vitro effects of photodynamic therapy on Aspergillus fumigatus. J. Antimicrob. Chemother. 48, 105-107.
43. Frimannsson, D. O., Grossi, M., Murtagh, J., Paradisi, F., and O'Shea, D. F. (2010). Light induced antimicrobial properties of a brominated boron difluoride (BF(2)) chelated tetraarylazadipyrromethene photosensitizer. J. Med. Chem. 53, 7337-7343.
44. Fuchs, B., O'Brien, E., Khoury, J. B., and Mylonakis, E. (2010). Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 1, 475-482.
45. Fuchs, B., Tang, R. J., and Mylonakis, E. (2007a). The temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis. PLoS ONE 2, e368. doi:10.1371/journal.pone.0000368
46. Fuchs, B., Tegos, G. P., Hamblin, M. R., and Mylonakis, E. (2007b). Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob. Agents Chemother. 51, 2929-2936.
47. Gasparetto, A., Lapinski, T. F., Zamuner, S. R., Khouri, S., Alves, L. P., Munin, E., and Salvador, M. J. (2010). Extracts from Alternanthera maritima as natural photosensitizers in photodynamic antimicrobial chemotherapy (PACT). J. Photochem. Photobiol. B Biol. 99, 15-20.
48. Gavalda, J., Len, O., San Juan, R., Aguado, J., Fortun, J., Lumbreras, C., Moreno, A., Munoz, P., Blanes, M., Ramos, A., Rufi, G., Gurgui, M., Torre-Cisneros, T., Montejo, M., Cuenca-Estrella, M., Rodriguez-Tudela, J., Pahissa, A., and RESI-TRA (Spanish Network for Research on Infection in Transplantation). (2005). Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin. Infect. Dis. 41, 52-59.
49. Gerik, K., Bhimireddy, S. R., Ryerse, J. S., Specht, C. A., and Lodge, J. K. (2008). PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 7, 1685-1698.
50. Gilaberte, Y., Aspiroz, C., Martes, M. P., Alcalde, V., Espinel-Ingroff, A., and Rezusta, A. (2011). Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J. Am. Acad. Dermatol. 65, 669-671.
51. Giroldo, L., Felipe, M. P., De Oliveira, M. A., Munin, E., Alves, L. P., and Costa, M. S. (2009). Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans.Lasers Med. Sci. 24, 109-112.
52. Giuliani, F., Martinelli, M., Cocchi, A., Arbia, D., Fantetti, L., and Roncucci, G. (2010). In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob. Agents Chemother. 54, 637-642.
53. Gonzales, F., Da Silva, S. H., Roberts, D. W., and Braga, G. U. (2010). Photodynamic inactivation of conidia of the fungi Metarhizium anisopliae and Aspergillus nidulans with methylene blue and toluidine blue. Photochem. Photobiol. 86, 653-661.
54. Gonzales, F., and Maisch, T. (2012). Photodynamic inactivation for controlling Candida albicans infections. Fungal Biol. 116, 1-10.
55. Gudlaugsson, O., Gillespie, S., Lee, K., Vande, Berg, J., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., and Diekema, D. (2003). Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37, 1172-1177.
56. Guo, Y., Rogelj, S., and Zhang, P. (2010). Rose bengal-decorated silica nanoparticles as photosensitizers for inactivation of Gram-positive bacteria. Nanotechnology 21, 065102.
57. Hamblin, M., Tegos, G. P., St. Denis, T., and Huang, L. (2011). Antimicrobial photodynamic therapy: can resistance develop Photodiagnosis Photodyn. Ther. 8, 178.
58. Harris, F., Chatfield, L. K., and Phoenix, D. A. (2005). Phenothiazinium based photosensitisers - photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug Targets 6, 615-627.
59. Holmes, A. R., Lin, Y. H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., Tanabe, K., Monk, B. C., and Cannon, R. D. (2008). ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob. Agents Chemother. 52, 3851-3862.
60. Holmes, A. R., Tsao, S., Ong, S. W., Lamping, E., Niimi, K., Monk, B. C., Niimi, M., Kaneko, A., Holland, B. R., Schmid, J., and Cannon, R. D. (2006). Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1and CDR2.Mol. Microbiol. 62, 170-186.
61. Horn, D., Neofytos, D., Anaissie, E., Fishman, J., Steinbach, W., Olyaei, A., Marr, K., Pfaller, M., and Chang, C., and Webster, K. (2009). Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48, 1695-1703.
62. Huang, L., Huang, Y. Y., Mroz, P., Tegos, G. P., Zhiyentayev, T., Sharma, S. K., Lu, Z., Balasubramanian, T., Krayer, M.,Ruzie, C.,Yang,E.,Kee,H.L.,Kirmaier, C., Diers, J. R., Bocian, D. F., Holten, D., Lindsey, J. S., and Hamblin, M. R. (2010a). Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother. 54, 3834-3841.
63. Huang, L., Terakawa, M., Zhiyentayev, T., Huang, Y. Y., Sawayama, Y., Jahnke, A., Tegos, G. P., Wharton, T., and Hamblin, M. R. (2010b). Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine 6, 442-452.
64. Hunt, D. W. (2002). Rostaporfin (Miravant Medical Technologies). Idrugs 5, 180-186.
65. Jia, Y., Joly, H., and Omri, A. (2010). Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa. J. Liposome Res. 20, 134-146.
66. Kamp, H., Tietz, H. J., Lutz, M., Piazena, H., Sowyrda, P., Lademann, J., and Blume-Peytavi, U. (2005). Anti-fungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses 48, 101-107.
67. Kim, B., Rutka, J. T., and Wchan, W. C. W.(2010).Nanomedicine. NewEngl. J. Med. 363, 2434-2443.
68. Kömerik, N., Wilson, M., and Poole, S. (2000). The effect of photodynamic action on two virulence factors of Gram-negative bacteria. Photochem. Photobiol. 72, 676-680.
69. Kronstad, J. W., Attarian, R., Cadieux, B., Choi, J., D'Souza, C. A., Griffiths, E. J., Geddes, J. M., Hu, G., Jung, W. H., Kretschmer, M., Saikia, S., and Wang, J. (2011). Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 9, 193-203.
70. Kumar, S., and Kimball, A. B. (2009). New antifungal therapies for the treatment of onychomycosis. Expert Opin. Investig. Drugs 18, 727-734.
71. Lafleur, M., Kumamoto, C. A., and Lewis, K. (2006). Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50, 3839-3846.
72. Lafleur, M., Qi, Q., and Lewis, K. (2010). Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54, 39-44.
73. Lam, M., Jou, P. C., Lattif, A. A., Lee, Y., Malbasa, C. L., Mukherjee, P. K., Oleinick, N. L., Ghannoum, M. A., Cooper, K. D., and Baron, E. D. (2011). Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans. Photochem. Photobiol. 87, 904-909.
74. Lambrechts, S., Aalders, M. C., and Van Marle, J. (2005). Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob. Agents Chemother. 49, 2026-2034.
75. Lamping, E., Baret, P. V., Holmes, A. R., Monk, B. C., Goffeau, A., and Cannon, R. D. (2010). Fungal PDR transporters: phylogeny, topology, motifs and function. Fungal Genet. Biol. 47, 127-142.
76. Lazarova, G. (1993). Effect of glutathione on rose bengal photosensitized yeast damage. Microbios 75, 39-43.
77. Leach, A. G., and Houk, K. N. (2002). Diels-Alder and ene reactions of singlet oxygen, nitroso compounds and triazolinediones: transition states and mechanisms from contemporary theory. Chem. Commun. (Camb.) 21, 1243-1255.
78. Lee, J., Kim, B. J., and Kim, M. N. (2010). Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg. Med. 42, 192-196.
79. Lee, Y., Almqvist, F., and Hultgren, S. J. (2003). Targeting virulence for antimicrobial chemotherapy. Curr. Opin. Pharmacol. 3, 513-519.
80. Lewis, K. (2001). Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999-1007.
81. Lewis, K. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357-372.
82. Lu, Z., Dai, T., Huang, L., Kurup, D. B., Tegos, G. P., Jahnke, A., Wharton, T., and Hamblin, M. R. (2010). Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.) 5, 1525-1533.
83. Lyon, J., Pedroso E Silva Azevedo Cde, M., Moreira, L. M., De Lima, C. J., and De Resende, M. A. (2011). Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia 172, 293-297.
84. Mang, T., Mikulski, L., and Hall, R. E. (2010). Photodynamic inactivation of normal and antifungal resistant Candida species. Photodiagnosis Photodyn. Ther. 7, 98-105.
85. Martins, C., Da Silva, D. L., Neres, A. T., Magalhães, T. F., Watanabe, G. A., Modolo, L. V., Sabino, A. A., De Fátima, A., and De Resende, M. A. (2009). Curcumin as a promising antifungal of clinical interest. J. Antimicrob. Chemother. 63, 337-339.
86. Mccarron, P., Donnelly, R. F., Marouf, W, and Calvert, D. E. (2007). Anti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticles. Int. J. Pharm. 340, 182-190.
87. Mima, E., Pavarina,A. C., Dovigo, L. N., Vergani, C. E., Costa, C. A., Kurachi, C., Bagnato,V. S. (2010). Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109, 392-401.
88. Mitra, S., Haidaris, C. G., Snell, S. B., Giesselman, B. R., Hupcher, S. M., and Foster, T. H. (2011). Effective photosensitization and selectivity in vivo of Candida albicans by mesotetra (N-methyl-4-pyridyl) porphine tetra tosylate. Lasers Surg. Med. 43, 324-332.
89. Mitton, D., and Ackroyd, R. (2008). A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn. Ther. 5, 103-111.
90. Morgan, J. J. J., Zheng, X., Pandey, S. K., and Pandey, R. K. (2010). Substrate affinity of photosensitizers derived from chlorophylla: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol. Pharm. 5, 1789-1804.
91. Müller, P., Guggenheim, B., and Schmidlin, P. R. (2007). Efficacy of gasiform ozone and photodynamic therapy on a multispecies oral biofilm in vitro. Eur. J. Oral Sci. 115, 77-80.
92. Nakonieczna, J., Michta, E., Rybicka, M., Grinholc, M., Gwizdek-Wiśniewska, A., and Bielawski, K. P. (2010). Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol. 10, 323. doi:10.1186/1471-2180-10-323
93. Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., and Webster, K., and Marr, K. (2009). Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry. Clin. Infect. Dis. 48, 265-273.
94. Neri, P., Mercanti, L., Mariotti, C., Salvolini, S., and Giovannini, A. (2010). Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results. Int. Ophthalmol. 30, 51-56.
95. Nitzan, Y., Gutterman, M., Malik, Z., and Ehrenberg, B. (1992). Inactivation of Gram-negative bacteria by photosensitized porphyrins. Photochem. Photobiol. 55, 89-96.
96. Ochsner, M. (1997). Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B Biol. 39, 1-18.
97. Oriel, S., and Nitzan,Y. (2010). Photoinactivation of Candida albicans by its own endogenous porphyrins. Curr. Microbiol. 60, 117-123.
98. Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J., Odds, F., and Rex, J. (2010). An insight into the antifungal pipeline: selected new molecules and beyond. Nat. Rev. Drug Discov. 9, 719-727.
99. Ozaki, K., Tanaka, K., Imamura, H., Hihara, T., Kameyama, T., Nonaka, H., Hirano, H., Matsuura, Y., and Takai, Y. (1996). Rom1p and Rom2p are GDP/GTP exchangeproteins (GEPs) for Rho1p small GTP binding proteins in Saccharomyces cerevisiae. EMBO J. 15, 2196-2207.
100. Paardekooper, M., Van Den Broek, P. J., De Bruijne, A. W., Elferink, J. G., Dubbelman, T. M., and Van Steveninck, J. (1992). Photodynamic treatment of yeast cells with the dye toluidine blue: all-or-none loss of plasma membrane barrier properties. Biochim. Biophys. Acta 1108, 86-90.
101. Pappas, P., Kauffman, C., Andes, D., Benjamin, D. Jr, Calandra, T., Edwards, J. Jr, Filler, S., Fisher, J., Kullberg, B., Ostrosky-Zeichner, L., Reboli, A., Rex, J., Walsh, T., Sobel, J., and Infectious Diseases Society of America. (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 503-535.
102. Park, B.,Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530.
103. Pereira, C., Romeiro, R. L., Costa, A. C., Machado, A. K., Junqueira, J. C., and Jorge, A. O. (2011). Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers Med. Sci. 26, 341-348.
104. Perni, S., Prokopovich, P., Pratten, J., Parkin, I. P., and Wilson, M. (2011). Nanoparticles: their potential use in antibacterial photodynamic therapy. Photochem. Photobiol. Sci. 10, 712-720.
105. Pfaller, M., Andes, D., Diekema, D., Espinel-Ingroff, A., Sheehan, D., and The Clsi Subcommittee for Antifungal Susceptibility Testing. (2010). Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCASTbroth microdilution methods. Drug Resist. Updat. 13, 180-195.
106. Pflumm, M. (2011). Caught on film. Nat. Med. 17, 650-653.
107. Philip, B., and Levin, D. E. (2001). Wsc1 and Mid2 are cell surface sensors for cell wall integrity signaling that act through Rom2, a guanine nucleotide exchange factor for Rho1. Mol. Cell. Biol. 21, 271-280.
108. Prates, R., Kato, I. T., Ribeiro, M. S., Tegos, G. P., and Hamblin, M. R. R. (2011). Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J. Antimicrob. Chemother. 66, 1525-1532.
109. Qiao, J., Li, R., Ding, Y., and Fang, H. (2010). Photodynamic therapy in the treatment of superficial mycoses: an evidence-based evaluation. Mycopathologia 170, 339-343.
110. Raab, O. (1900). Ueber diewirkung fluoreszierender stoffe auf infusori. Z. Biol. 39, 524-536.
111. Raghavendra, M., Koregol, A., and Bhola, S. (2009). Photodynamic therapy: a targeted therapy in periodontics. Aust. Dent. J. 54(SUPPL.1), S102-S109.
112. Rentz, A., Halpern, M. T., and Bowden, R. (1998). The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin. Infect. Dis. 27, 781-788.
113. Schuckert, K., Jopp, S., and Muller, U. (2006). De novo grown bone on exposed implant surfaces using photodynamic therapy and recombinant human bone morphogenetic protein-2: case report. Implant Dent. 15, 361-365.
114. Schwiertz, J., Wiehe, A., Grafe, S., Gitter, B., and Epple, M. (2009). Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials 30, 3324-3331.
115. Sharma, S., Dai, T., Kharkwal, G. B., Huang, Y. Y., Huang, L., De Arce, V. J., Tegos, G. P., and Hamblin, M. R. (2011). Drug discovery of antimicrobial photosensitizers using animal models. Curr. Pharm. Des. 17, 1303-1319.
116. Sibani, S., Mccarron, P. A., Woolfson, A. D., and Donnelly, R. F. (2008). Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin. Drug Deliv. 5, 1241-1254.
117. Simons, V., Morrissey, J. P., Latijnhouwers, M., Csukai, M., Cleaver, A., Yarrow, C., and Osbourn, A. (2006). Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 50, 2732-2740.
118. Singleton, D. A., Hang, C., Szymanski, M. J., Meyer, M. P., Leach, A. G., Kuwata, K. T., Chen, J. S., Greer, A., Foote, C. S., and Houk, K. N. (2003). Mechanism of ene reactions of singlet oxygen. A two-step no-intermediate mechanism. J. Am. Chem. Soc. 125, 1319-1328.
119. Smijs, T., Bouwstra, J. A., Talebi, M., and Pavel, S. (2007). Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment. J. Antimicrob. Chemother. 60, 750-759.
120. Smijs, T., Mulder, A. A., Pavel, S., Onder-water, J. J., Koerten, H. K., and Bouwstra, J. A. (2008). Morphological changes of the dermatophyte Trichophyton rubrum after photodynamic treatment: a scanning electron microscopy study. Med. Mycol. 46, 315-325.
121. Smijs, T., and Pavel, S. (2011). The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum. Photochem. Photobiol. 87, 2-13.
122. Smijs, T. G., Pavel, S., Talebi, M., and Bouwstra, J. A. (2009). Preclinical studies with 5,10,15-tris(4-methylpyridinium)-20-phenyl-[21H,23H]-porphine trichloride for the photodynamic treatment of superficial mycoses caused by Trichophyton rubrum. Photochem. Photobiol. 85, 733-739.
123. Snell, S., Foster, T. H., and Haidaris, C. G. (2011). miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy. Photochem. Photobiol. doi:10.1111/j.1751-1097. 2011.01039.x [Epub ahead of print].
124. So, C., Tsang, P. W., Lo, P. C., Seneviratne, C. J., Samaranayake, L. P., and Fong, W. P. (2010). Photodynamic inactivation of Candida albicans by BAM-SiPc. Mycoses 53, 215-220.
125. Soares, B., Alves, O. A., Ferreira, M. V., Amorim, J. C., Sousa, G. R., Silveira Lde, B., Prates, R. A., Avila, T. V., Baltazar Lde, M., De Souza Dda, G., Santos, D. A., Modolo, L. V., Cisalpino, P. S., and Pinotti, M. (2011). Cryptococcus gattii: in vitro susceptibility to photodynamic inactivation. Photochem. Photobiol. 87, 357-364.
126. Soares, B., Da Silva, D. L., Sousa, G. R., Amorim, J. C., De Resende, M. A., Pinott, I. M., and Cisalpino, P. S. (2008). In vitro photodynamic inactivation of Candida spp. growth and adhesion to buccal epithelial cells. J. Photochem. Photobiol. B Biol. 94, 65-70.
127. Sobel, J. (2007). Vulvovaginal candidosis. Lancet 369, 1961-1971.
128. Sotiriou, E., Koussidou-Eremonti, T., Chaidemenos, G., Apalla, Z., and Ioannides, D. (2010). Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm. Venereol. 90, 216-217.
129. Soukos, N., Chen, P. S., Morris, J. T., Ruggiero, K., Abernethy, A. D., Som, S., Foschi, F., Doucette, S., Bammann, L. L., Fontana, C. R., Doukas, A. G., and Stashenko, P. P. (2006). Photodynamic therapy for endodontic disinfection. J. Endod. 32, 979-984.
130. Souza, R., Junqueira, J. C., Rossoni, R. D., Pereira, C. A., Munin, E., and Jorge, A. O. (2010). Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue,malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med. Sci. 25, 385-389.
131. St. Denis, T., Dai, T., Izikson, L., Astrakas, C., Anderson, R. R., Hamblin, M. R., and Tegos, G. P. (2011a). All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence 2, 6.
132. St. Denis, T., Huang, L., Dai, T., and Hamblin, M. R. (2011b). Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Photochem. Photobiol. 87, 707-713.
133. Strakhovskaia, M., Belenikina, N. S., Ivanova, E.V., Chemeris, I. U. K., and Stranadko, E. F. (2002). The photodynamic inactivation of Candida guilliermondii in the presence of photodithazine. Mikrobiologiia 71, 349-353.
134. Takahashi, P., Toups, H. J., Greenberg, D. B.,Dimopoullos,G.T., and Rusoff,L. L. (1975). Irradiation of Escherichia coli in the visible spectrum with a tunable organic-dye laser energy source. Appl. Microbiol. 29, 63-67.
135. Tanielian, C., Mechin, R., Seghrouchni, R., and Schweitzer, C. (2000). Mechanistic and kinetic aspects of photosensitization in the presence of oxygen. Photochem. Photobiol. 71, 12-19.
136. Tavares, A., Carvalho, C. M., Faustino, M. A., Neves, M. G., Tomé, J. P., Tomé, A. C., Cavaleiro, J. A., Cunha, A., Gomes, N. C., Alves, E., and Almeida, A. (2010). Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar. Drugs 8, 91-105.
137. Tedeschi, M., Varano, M., Schiano Lomoriello, D., Scassa, C., and Parisi, V. (2007). Photodynamic therapy outcomes in a case of macular choroidal neovascularization secondary to Candida endophthalmitis. Eur. J. Ophthalmol. 17, 124-127.
138. Tegos, G., Anbe, M., Yang, C., Demidova, T. N., Satti, M., Mroz, P., Janjua, S., Gad, F., and Hamblin, M. R. (2006). Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob. Agents Chemother. 50, 1402-1410.
139. Tegos, G., and Hamblin, M. R. (2006). Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob. Agents Chemother. 50, 196-203.
140. Tegos, G., Stermitz, F. R., Lomovskaya, O., and Lewis, K. (2002). Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46 3133-3141.
141. Tegos, G. P., Demidova, T. N., Arcila-Lopez, D., Lee, H., Wharton, T., Gali, H., and Hamblin, M. R. (2005). Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12, 1127-1135.
142. Teichert, M., Jones, J. W., Usacheva, M. N.,andBiel,M.A. (2002). Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93, 155-160.
143. Tsai, T., Yang, Y. T., Wang, T. H., Chien, H. F., and Chen, C. T. (2009). Improved photodynamic inactivation of Gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg. Med. 41, 316-322.
144. Tubby, S., Wilson, M., and Nair, S. P. (2009). Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC Microbiol. 9, 211. doi:10.1186/1471-2180-9-211
145. Valko, M., Morris, H., and Cronin, M. T. (2005). Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208.
146. Vermout, S., Tabart, J., Baldo, A., Mathy, A., Losson, B., and Mignon, B. (2008). Pathogenesis of dermatophytosis. Mycopathologia 166, 267-275.
147. Vilella, F., Herrero, E., Torres, J., and De La Torre-Ruiz, M. A. (2005). Pkc1 and the upstream elements of the cell wall integrity pathway in Saccharomyces cerevisiae, Rom2 and Mlt1, are required for cellular responses to oxide stress. J. Biol. Chem. 280, 9149-9159.
148. Wainwright, M., Byrne, M. N., and Gattrell, M. A. (2006). Phenothiazinium-based photobactericidal materials. J. Photochem. Photobiol. B Biol. 84, 227-230.
149. Xavier, J. (2011). Social interaction in synthetic and natural microbial communities Mol. Syst. Biol. 7, 483.
150. Zolfaghari, P., Packer, S., Singer, M., Nair, S. P., Bennett, J., Street, C., and Wilson, M. (2009). In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol. 9, 27. doi:10.1186/1471-2180-9-2